Guest: Dr. James Hudson is Group Leader of the Organoid Research Laboratory at the QIMR Berghofer Medical Research Institute in Brisbane, Australia, whose research is focused on developing state-of-the-art bioengineering approaches for human 3D organoids to use for studying cardiac biology and discovering new heart disease therapeutics. Featured Products and Resources: STEMdiff™ Cardiomyocyte Webinar: Modeling Arrhythmias Using hPSC-Derived Cardiomyocytes and Tracking Their Excitability Resources and Links Stimulating Hair Growth - Investigators have demonstrated that quiescent hair follicles can be stimulated to grow by small molecules that activate autophagy. Organoid Model of Fibrotic Lung Disease - Researchers used ESC-derived 3D organoids to model fibrotic lung disease, and identified a possible pathogenic mechanism. Antibody Conditioning for HSC Transplants - A transplant of mismatched HSCs without immune suppression by chemotherapy or radiation was successful in mice by performing a conditioning treatment with six antibodies. Improving Pancreatic Islet Transplantation - Researchers have identified a protein that improves revascularization of pancreatic islet grafts, and is a potential target for enhancing transplant outcomes in type 1 diabetes. Reprogramming Scar Tissue into Heart Muscle - For the first time, scientists have developed a stable, reproducible, and minimilistic platform to reprogram human fibroblast cells into cardiomyocytes. Photo Reference: Courtesy of Dr. James Hudson Subscribe to our newsletter! Never miss updates about new episodes. Subscribe